Physician profile
Dylan Carroll
NPI 1881198497
$1,611.36
in general payments reported to CMS, 2019-2025
12 companies · $1,126 in 2025
The $1,126 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $157 · 2022: $22.16 · 2023: $160 · 2024: $147 · 2025: $1,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,017 · Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,017.09 |
| Food and Beverage | $415.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $877.37 | 2025 | Blueprint Patient Specific Instrumentation |
| Medtronic, INC. | $215.48 | 2023-2025 | Signia, Ligasure, Interstim |
| Boston Scientific Corporation | $182.78 | 2025 | Axonics |
| Standard Bariatrics, INC. | $119.28 | 2021 | |
| Baxter Healthcare | $65.03 | 2021-2024 | Tisseel |
| Acera Surgical, INC. | $27.29 | 2025 | Restrata Wound Matrix |
| Cerus Corporation | $23.63 | 2023 | Intercept Blood System For Platelets |
| Terumo Medical Corporation | $22.16 | 2022 | |
| Axonics, INC. | $21.32 | 2024 | Axonics |
| Polynovo North America LLC | $19.16 | 2024 | Novosorb Btm |
| Pacira Pharmaceuticals Incorporated | $19.11 | 2025 | Exparel |
| Cardiovascular Systems INC. | $18.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.